Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma

P McLellan, J Henriques, F Ksontini, S Doat… - Clinics and research in …, 2021 - Elsevier
In metastatic pancreatic adenocarcinoma, a high neutrophil-to-lymphocyte ratio (NLR) at
diagnosis is a marker of poor prognosis. The prognostic role of baseline NLR and NLR …

Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma

P McLellan, J Henriques, F Ksontini, S Doat, P Hammel… - 2021 - pubmed.ncbi.nlm.nih.gov
In metastatic pancreatic adenocarcinoma, a high neutrophil-to-lymphocyte ratio (NLR) at
diagnosis is a marker of poor prognosis. The prognostic role of baseline NLR and NLR …

Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma

P Mclellan, J Henriques, F Ksontini, S Doat… - Clinics and Research in …, 2021 - hal.science
In metastatic pancreatic adenocarcinoma, a high neutrophil-to-lymphocyte ratio (NLR) at
diagnosis is a marker of poor prognosis. The prognostic role of baseline NLR and NLR …

Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma

P Mclellan, J Henriques, F Ksontini… - … and Research in …, 2021 - hal.sorbonne-universite.fr
In metastatic pancreatic adenocarcinoma, a high neutrophil-to-lymphocyte ratio (NLR) at
diagnosis is a marker of poor prognosis. The prognostic role of baseline NLR and NLR …

Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma.

P McLellan, J Henriques, F Ksontini, S Doat… - Clinics and Research …, 2020 - europepmc.org
In metastatic pancreatic adenocarcinoma, a high neutrophil-to-lymphocyte ratio (NLR) at
diagnosis is a marker of poor prognosis. The prognostic role of baseline NLR and NLR …

Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma

P McLellan, J Henriques, F Ksontini, S Doat… - Clinics and Research in …, 2021 - Elsevier
In metastatic pancreatic adenocarcinoma, a high neutrophil-to-lymphocyte ratio (NLR) at
diagnosis is a marker of poor prognosis. The prognostic role of baseline NLR and NLR …

[PDF][PDF] Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma

P Mclellan, J Henriques, F Ksontini, S Doat, P Hammel… - hal.sorbonne-universite.fr
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic
adenocarcinoma Page 1 HAL Id: hal-03477687 https://hal.sorbonne-universite.fr/hal-03477687 …